Microglial TREM2 in amyotrophic lateral sclerosis
Developmental Neurobiology · 2022-01 · 82 (1) · 125-137
DOI: 10.1002/dneu.22864 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Developmental Neurobiology, online erschienen am 18.12.2021. Verfasst von Manling Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Membrane Glycoproteins, Microglia, Neurodegenerative Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is an aggressive motor neuron degenerative disease characterized by selective loss of both upper and lower motor neurons. The mechanisms underlying disease initiation and progression are poorly understood. The involvement of nonmotor neuraxis emphasizes the contribution of glial cells in disease progress. Microglia comprise a unique subset of glial cells and are the principal immune cells in the central nervous system (CNS). Triggering receptor expressed on myeloid cell 2 (TREM2) is a surface receptor that, within the CNS, is exclusively expressed on microglia and plays crucial roles in microglial proliferation, migration, activation, metabolism, and phagocytosis. Genetic evidence has linked TREM2 to neurodegenerative diseases including ALS, but its function in ALS pathogenesis is largely unknown. In this review, we summarize how microglial activation, with a specific focus on TREM2 function, affects ALS progression clinically and experimentally. Understanding microglial TREM2 function will help pinpoint the molecular target for ALS treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Long-Jun Wu
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Xie, M., Zhao, S., Bosco, D. B., Nguyen, A., & Wu, L. J. (2022). Microglial TREM2 in amyotrophic lateral sclerosis. Developmental Neurobiology, 82(1), 125-137. https://doi.org/10.1002/dneu.22864
Vancouver
Xie M, Zhao S, Bosco DB, Nguyen A, Wu LJ. Microglial TREM2 in amyotrophic lateral sclerosis. Developmental Neurobiology. 2022;82(1):125-137. doi:10.1002/dneu.22864
BibTeX
@article{Xie2022,
author = {Xie, Manling and Zhao, Shunyi and Bosco, Dale B and Nguyen, Aivi and Wu, Long-Jun},
title = {Microglial TREM2 in amyotrophic lateral sclerosis},
journal = {Developmental Neurobiology},
year = {2022},
volume = {82},
number = {1},
pages = {125--137},
doi = {10.1002/dneu.22864}
}
EUVIMED